Welcome to LookChem.com Sign In|Join Free

CAS

  • or

218451-56-0

Post Buying Request

218451-56-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

218451-56-0 Usage

General Description

1-(amino(3,4-difluorophenyl)methyl)cyclobutanol is a chemical compound that contains a cyclobutanol ring with an attached amino group and a 3,4-difluorophenyl methyl group. It is a chiral compound due to the presence of the cyclobutanol ring, which contains stereocenters. This chemical may have potential pharmaceutical applications, as cyclobutanol-containing compounds have been investigated for their biological activities, including as potential antiviral and anti-inflammatory agents. The presence of the difluorophenyl group also suggests potential use in medicinal chemistry due to the influence of fluorine in drug design. However, further research and testing would be required to fully understand the properties and potential uses of this compound.

Check Digit Verification of cas no

The CAS Registry Mumber 218451-56-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,8,4,5 and 1 respectively; the second part has 2 digits, 5 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 218451-56:
(8*2)+(7*1)+(6*8)+(5*4)+(4*5)+(3*1)+(2*5)+(1*6)=130
130 % 10 = 0
So 218451-56-0 is a valid CAS Registry Number.

218451-56-0Upstream product

218451-56-0Downstream Products

218451-56-0Relevant articles and documents

Oxazolidinones as alpha 1A receptor antagonists

-

, (2008/06/13)

This invention is directed to oxazolidinone compounds which are selective antagonists for human alpha 1A receptors. This invention is also related to uses of these compounds for lowering intraocular pressure, inhibiting cholesterol synthesis, relaxing lower urinary tract tissue, the treatment of benign prostatic hyperplasia, impotency, cardiac arrhythmia and for the treatment of any disease where the antagonism of the alpha 1A receptor may be useful. The invention further provides a pharmaceutical composition comprising a therapeutically effective amount of the above-defined compounds and a pharmaceutically acceptable carrier.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 218451-56-0